The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel
Abstract
OBJECTIVE: New information warrants updated recommendations for the 4 central issues in antiretroviral therapy: when to start, what drugs to start with, when to change, and what to change to. These updated recommendations are intended to guide practicing physicians actively involved in human immunodeficiency virus (HIV)- and acquired immunodeficiency syndrome (AIDS)-related care. PARTICIPANTS: In 1995, physicians with specific expertise in HIV-related basic science and clinical research, antiretroviral therapy, and HIV patient care were invited by the International AIDS Society-USA to serve on a volunteer panel. In 1999, others were invited to broaden international representation. The 17-member panel met regularly in closed meetings between its last report in 2000 and April 2002 to review current data. The effort was sponsored and funded by the International AIDS Society-USA, a not-for-profit physician education organization. EVIDENCE AND CONSENSUS PROCESS: The full panel was convened in late 2000 and assigned 7 section committees. A section writer and 3 to 5 section committee members (each panel member served on numerous sections) identified relevant evidence and prepared draft recommendations. Basic science, clinical research, and epidemiologic data from the published literature and abstracts from recent (within 2 years) scientific conferences were considered by strength of evidence. Extrapolations from basic science data and expert opinion of the panel members were included as evidence. Draft sections were combined and circulated to the entire panel and discussed in a series of full-panel conference calls until consensus was reached. Final recommendations represent full consensus agreement of the panel. CONCLUSIONS: Because of increased awareness of the activity and toxicity of current drugs, the threshold for initiation of therapy has shifted to a later time in the course of HIV disease. However, the optimal time to initiate therapy remains imprecisely defined. Availability of new drugs has broadened options for therapy initiation and management of treatment failure, which remains a difficult challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Self-citationCarr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
Self-citationFinzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
Adverse effects of antiretroviral therapy
Carr, A., & Cooper, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02854-3 · Cited by 1,057
Self-citationBangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033
Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., et al. (2000) · JAMA · doi:10.1001/jama.283.3.381 · Cited by 1,012
Self-citationImmune control of HIV-1 after early treatment of acute infection
Rosenberg, E. S., Altfeld, M., Poon, S. H., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D'Aquila, R. T., Goulder, P. J. R., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
Shankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H., He, X., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10489-10502.1999 · Cited by 926 · cited 1×
“Finally, the genetic complexity of HIV in persons increases with time, and this may facilita te escape from host immune defenses.(26) These considerations support use of a CD4 cell count threshold higher than 200/μL.”
BackgroundImproved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
Hogg, R. S. (1998) · JAMA · doi:10.1001/jama.279.6.450 · Cited by 850
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A. S., Korber, B. T., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402101 · Cited by 807
Mitochondrial toxicity of antiviral drugs
Lewis, W., & Dalakas, M. C. (1995) · Nature Medicine · doi:10.1038/nm0595-417 · Cited by 770
Hirsch, M. S., Brun-Vézinet, F., D'Aquila, R. T., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., Mellors, J. W., Clotet, B., Conway, B., et al. (2000) · JAMA · doi:10.1001/jama.283.18.2417 · Cited by 766
Self-citationHogg, R. S. (2001) · JAMA · doi:10.1001/jama.286.20.2568 · Cited by 728
Deeks, S. G., Wrin, T., Liegler, T., Hoh, R., Hayden, M., Barbour, J. D., Hellmann, N. S., Petropoulos, C. J., McCune, J. M., Hellerstein, M. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440702 · Cited by 653
MacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., et al. (1998) · Journal of Infectious Diseases · doi:10.1086/515613 · Cited by 640
Bacterial Pneumonia in Persons Infected with the Human Immunodeficiency Virus
Hirschtick, R. E., Glassroth, J., Jordan, M. C., Wilcosky, T. C., Wallace, J. M., Kvale, P. A., Markowitz, N., Rosen, M. J., Mangura, B. T., & Hopewell, P. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331305 · Cited by 615
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Périard, D., Telenti, A., Sudre, P., Cheseaux, J.-J., Halfon, P., Reymond, M. J., Marcovina, S. M., Glauser, M. P., Nicod, P., Darioli, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.7.700 · Cited by 605
Saint-Marc, T., Partisani, M., Poizot-Martin, I., Bruno, F., Rouviere, O., Lang, J.-M., Gastaut, J.-A., & Touraine, J.-L. (1999) · AIDS · doi:10.1097/00002030-199909100-00009 · Cited by 581
“Buffalo hump” in men with HIV-1 infection
Lo, J. C., Mulligan, K., Tai, V. W., Algren, H., & Schambelan, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11443-x · Cited by 567
Hirsch, M. S., Conway, B., D'Aquila, R. T., Johnson, V. A., Brun-Vézinet, F., Clotet, B., Demeter, L. M., Hammer, S. M., Jacobsen, D. M., Kuritzkes, D. R., et al. (1998) · JAMA · doi:10.1001/jama.279.24.1984 · Cited by 563
Self-citationLi, T., Tubiana, R., Katlama, C., Calvez, V, Mohand, H. A., & Autran, B. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10291-4 · Cited by 544
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Tebas, P., Powderly, W. G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S. L., & Yarasheski, K. E. (2000) · AIDS · doi:10.1097/00002030-200003100-00005 · Cited by 532
Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., Lo, J. C., & Schambelan, M. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00005 · Cited by 518
(2002) · PsycEXTRA Dataset · doi:10.1037/e548362006-001 · Cited by 517
Behrens, G., Dejam, A., Schmidt, H., Balks, H.-J., Brabant, G., Körner, T., Stoll, M., & Schmidt, R. E. (1999) · AIDS · doi:10.1097/00002030-199907090-00001 · Cited by 515
Schuurman, R., Nijhuis, M., van Leeuwen, R., Schipper, P., de Jong, D., Collis, P., Danner, S. A., Mulder, J., Loveday, C., Christopherson, C., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1411 · Cited by 503
Baxter, J. D., Mayers, D. L., Wentworth, D. N., Neaton, J. D., Hoover, M. L., Winters, M. A., Mannheimer, S., Thompson, M., Abrams, D. I., Brizz, B., et al. (2000) · AIDS · doi:10.1097/00002030-200006160-00001 · Cited by 494
Self-citationKovacs, J. A., Baseler, M., Dewar, R. J., Vogel, S., Davey, R. T., Falloon, J., Polis, M. A., Walker, R. E., Stevens, R., Salzman, N. P., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320904 · Cited by 425
Sex differences in HIV-1 viral load and progression to AIDS
Farzadegan, H., Hoover, D. R., Astemborski, J., Lyles, C. M., Margolick, J. B., Markham, R. B., Quinn, T. C., & Vlahov, D. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02372-1 · Cited by 416
Neuvonen, P. J., Kantola, T., & Kivistö, K. T. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90165-5 · Cited by 406
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
Purnell, J. Q., Zambon, A., Knopp, R. H., Pizzuti, D. J., Achari, R., Leonard, J. M., Locke, C., & Brunzell, J. D. (2000) · AIDS · doi:10.1097/00002030-200001070-00006 · Cited by 387
DeSimone, J. A., Pomerantz, R. J., & Babinchak, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00013 · Cited by 383
Crowe, S. M., Carlin, J. B., Stewart, K., Lucas, C. R., & Hoy, J. (1991) · PubMed · Cited by 375
Lyles, R. H., Muñoz, Á., Yamashita, T. E., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315339 · Cited by 362
Prevalence and Predictive Value of Intermittent Viremia With Combination HIV Therapy
Havlir, D. V. (2001) · JAMA · doi:10.1001/jama.286.2.171 · Cited by 358
Metabolic effects of indinavir in healthy HIV-seronegative men
Noor, M. A., Lo, J. C., Mulligan, K., Schwarz, J.-M., Halvorsen, R. A., Schambelan, M., & Grunfeld, C. (2001) · AIDS · doi:10.1097/00002030-200105040-00001 · Cited by 350
Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection
Little, S. J. (1999) · JAMA · doi:10.1001/jama.282.12.1142 · Cited by 335
DeGruttola, V., Dix, L., D'Aquila, R., Holder, D., Phillips, A., Ait-Khaled, M., Baxter, J., Clevenbergh, P., Hammer, S., Harrigan, R., et al. (2000) · Antiviral Therapy · doi:10.1177/135965350000500112 · Cited by 326
Self-citationHavlir, D. V., Marschner, I. C., Hirsch, M. S., Collier, A. C., Tebas, P., Bassett, R. L., Ioannidis, J. P. A., Holohan, M. K., Leavitt, R., Boone, G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391801 · Cited by 307
Self-citationTuberculosis in patients with the acquired immunodeficiency syndrome
Richard, R. (1987) · Medical Entomology and Zoology · Cited by 297
The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients
Schapiro, J. M., Winters, M. A., Stewart, F., Efron, B., Norris, J., Kozal, M. J., & Merigan, T. C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-12-199606150-00003 · Cited by 296
Hughes, M. D., Johnson, V. A., Hirsch, M. S., Bremer, J. W., Elbeik, T., Erice, A., Kuritzkes, D. R., Scott, W. A., Spector, S. A., Basgoz, N., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00001 · Cited by 280
Self-citationDrug Resistance Mutations in HIV-1.
D’Aquila, R. T., Schapiro, J., Brun‐Vézinet, F., Clotet, B., Conway, B., Demeter, L. M., Grant, R. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., et al. (2002) · PubMed · Cited by 276
Self-citationRaboud, J. M., Montaner, J. S. G., Conway, B., Rae, S., Reiss, P., Vella, S., Cooper, D., Lange, J., Harris, M., Wainberg, M. A., et al. (1998) · AIDS · doi:10.1097/00002030-199813000-00008 · Cited by 259
Self-citationvan der Valk, M., Kastelein, J. J. P., Murphy, R. L., van Leth, F., Katlama, C., Horban, A., Glesby, M., Behrens, G., Clotet, B., Stellato, R. K., et al. (2001) · AIDS · doi:10.1097/00002030-200112070-00008 · Cited by 253
Tuldrà, A., Fumaz, C. R., Ferrer, M. J., Bayés, R., Arnó, A., Balagué, M., Bonjoch, A., Jou, A., Negredo, E., Paredes, R., et al. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200011010-00003 · Cited by 244
Marschner, I. C., Collier, A. C., Coombs, R. W., D'Aquila, R. T., DeGruttola, V., Fischl, M. A., Hammer, S. M., Hughes, M. D., Johnson, V. A., Katzenstein, D. A., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/513823 · Cited by 240
Self-citationItraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
Neuvonen, P. J., & Jalava, K.-M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90167-8 · Cited by 238
Murphy, R. L., Brun, S., Hicks, C., Eron, J. J., Gulick, R., King, M., White, A. C., Benson, C., Thompson, M., Kessler, H. A., et al. (2001) · AIDS · doi:10.1097/00002030-200101050-00002 · Cited by 238
Self-citationKempf, D. J., Rode, R. A., Xu, Y., Sun, E., Heath-Chiozzi, M. E., Valdes, J., Japour, A. J., Danner, S., Boucher, C., Molla, A., et al. (1998) · AIDS · doi:10.1097/00002030-199805000-00001 · Cited by 222
Hockett, R. D., Michael Kilby, J., Derdeyn, C. A., Saag, M. S., Sillers, M., Squires, K., Chiz, S., Nowak, M. A., Shaw, G. M., & Bucy, R. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1545 · Cited by 215
Self-citationLonergan, J. T., Behling, C., Pfander, H., Hassanein, T. I., & Mathews, W. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313912 · Cited by 208
Barouch, D. H., Craiu, A., Kuroda, M. J., Schmitz, J. E., Zheng, X. X., Santra, S., Frost, J. D., Krivulka, G. R., Lifton, M. A., Crabbs, C. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050417697 · Cited by 200
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy
Cohen, C. J., Hunt, S., Sension, M., Farthing, C., Conant, M., Jacobson, S., Nadler, J., Verbiest, W., Hertogs, K., Ames, M., et al. (2002) · AIDS · doi:10.1097/00002030-200203080-00009 · Cited by 195
García, F., Plana, M., Ortiz, G. M., Bonhoeffer, S., Soriano, A., Vidal, C., Cruceta, A., Arnedo, M., Gil, C., Pantaleo, G., et al. (2001) · AIDS · doi:10.1097/00002030-200106150-00002 · Cited by 193
Self-citationPredictors of optimal virological response to potent antiretroviral therapy
Powderly, W. G., Saag, M. S., Chapman, S. K., Yu, G. W., Quart, B. D., & Clendeninn, N. J. (1999) · AIDS · doi:10.1097/00002030-199910010-00009 · Cited by 192
Self-citationRitonavir and saquinavir combination therapy for the treatment of HIV infection
Cameron, W., Japour, A. J., Xu, Y., Hsu, A., Mellors, J., Farthing, C., Cohen, C., Poretz, D., Markowitz, M., Follansbee, S., et al. (1999) · AIDS · doi:10.1097/00002030-199902040-00009 · Cited by 191
Clements‐Mann, M. L., Weinhold, K., Matthews, T. J., Graham, B. S., Gorse, G. J., Keefer, M. C., McElrath, M. J., Hsieh, R., Mestecky, J., Zolla‐Pazner, S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515288 · Cited by 189
Is, F., Belitsos, P. C., Chaisson, R. E., & Moore, R. D. (1995) · PubMed · Cited by 188
Kahn, S. E., Beard, J. C., Schwartz, M. W., Ward, W. K., Ding, H. L., Bergman, R. N., Taborsky, G. J., & Porte, D. (1989) · Diabetes · doi:10.2337/diab.38.5.562 · Cited by 181
Yamashita, T. E., Phair, J. P., Muñoz, A., Margolick, J. B., Detels, R., O'Brien, S. J., Mellors, J. W., Wolinsky, S. M., & Jacobson, L. P. (2001) · AIDS · doi:10.1097/00002030-200104130-00009 · Cited by 178
Dybul, M. R., Chun, T., Yoder, C. P., Hidalgo, B., Belson, M., Hertogs, K., Larder, B. A., Dewar, R. L., Fox, C. H., Hallahan, C. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261568398 · Cited by 154
Ruiz, L., Carcelain, G., Martínez‐Picado, J., Frost, S. D. W., Marfil, S., Paredes, R., Romeu, J., Ferrer, E., Morales-Lopetegi, K., Autran, B., et al. (2001) · AIDS · doi:10.1097/00002030-200106150-00001 · Cited by 153
Hance, A. J., Lemiale, V., Izopet, J., Lecossier, D., Joly, V., Massip, P., Mammano, F., Descamps, D., Brun‐Vézinet, F., & Clavel, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6410-6417.2001 · Cited by 136
Dong, K. L., Bausserman, L., Flynn, M. M., Dickinson, B. P., Flanigan, T., Mileno, M. D., Tashima, K. T., & Carpenter, C. C. (1999) · PubMed · Cited by 133
Self-citationCoghlan, M. E., Sommadossi, J., Jhala, N. C., Many, W. J., Saag, M. S., & Johnson, V. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323783 · Cited by 125
Self-citationTarwater, P. M., Margolick, J. B., Jin, J., Phair, J. P., Detels, R., Rinaldo, C. R., Giorgi, J. V., & Muñoz, A. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200106010-00012 · Cited by 115
Structured Treatment Interruptions for the Management of HIV Infection
Lori, F., & Lisziewicz, J. (2001) · JAMA · doi:10.1001/jama.286.23.2981 · Cited by 108
Pirmohamed, M., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00006 · Cited by 108
Deeks, S. G., Hoh, R., Grant, R. M., Wrin, T., Barbour, J. D., Narvaez, A., Cesar, D., Abe, K., Hanley, M. B., Hellmann, N. S., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338467 · Cited by 107
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy
Kaufmann, G. R., Bloch, M., Zaunders, J., Smith, D. E., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200005260-00007 · Cited by 101
Self-citationLenzo, N. P., Garas, B. A., & French, M. A. (1997) · AIDS · doi:10.1097/00002030-199710001-00003 · Cited by 99
Osteonecrosis in Patients Infected with Human Immunodeficiency Virus: A Case‐Control Study
Glesby, M. J., Hoover, D. R., & Vaamonde, C. (2001) · The Journal of Infectious Diseases · doi:10.1086/322779 · Cited by 96
Gulick, R. M., Hu, X. J., Fiscus, S. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315867 · Cited by 91
Brambilla, D. J., Reichelderfer, P. S., Bremer, J. W., Shapiro, D. E., Hershow, R. C., Katzenstein, D. A., Hammer, S. M., Jackson, J. B., Collier, A. C., SPERLING, R. S., et al. (1999) · AIDS · doi:10.1097/00002030-199911120-00009 · Cited by 77
Self-citationHypersensitivity Syndrome Associated with Efavirenz Therapy
Bossi, P., Colin, D., Bricaire, F., & Caumes, É. (2000) · Clinical Infectious Diseases · doi:10.1086/313629 · Cited by 75
Bone Mineral Content Is Lower in Prepubertal HIV-Infected Children
Arpadi, S. M., Horlick, M. N. B., Thornton, J. C., Cuff, P. A., Wang, J., & Kotler, D. P. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00004 · Cited by 73
US Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA); USPHS/IDSA Prevention of Opportunistic Infections Working Group (2001) · HIV Clinical Trials · doi:10.1310/aqml-uabk-5llb-e615 · Cited by 72
Hyperlipidemia Associated with Protease Inhibitor Therapy
Echevarria, K. L., Hardin, T. C., & Smith, J. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18174 · Cited by 72
Demeter, L. M., Hughes, M. D., Coombs, R. W., Jackson, J. B., Grimes, J. M., Bosch, R. J., Fiscus, S. A., Spector, S. A., Squires, K., Fischl, M. A., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00007 · Cited by 65
Self-citationSex differences in HIV-1 viral load and progression to AIDS
Junghans, C., Ledergerber, B., Chan, P., Weber, R. K., & Egger, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75645-2 · Cited by 63
Lepri, A. C., Miller, V., Phillips, A. N., et al. (2001) · AIDS · doi:10.1097/00002030-200101050-00008 · Cited by 55
Brivet, F. G., Nion–Larmurier, I., Mégarbane, B., Slama, A., Brivet, M., Rustin, P., & Münnich, A. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80088-4 · Cited by 54
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA
Rizzardi, G. P., de Boer, R. J., Hoover, S. B., Tambussi, G., Chapuis, A. G., Halkic, N., Bart, P., Miller, V., Staszewski, S., Notermans, D. W., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9079 · Cited by 50
Palmer, S., Margot, N., Gilbert, H., Shaw, N., Buckheit, R. W., & Miller, M. D. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201316912772 · Cited by 46
Roberts, A. D., Muesing, R. A., Parenti, D. M., Hsia, J., Wasserman, A. G., & Simon, G. L. (1999) · Clinical Infectious Diseases · doi:10.1086/520231 · Cited by 44
Petit, J., Duong, M., Duvillard, L., Piroth, L., Grappin, M., Vergès, B. L., Chavanet, P., Brun, J. M., & Portier, H. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978655 · Cited by 42
Immunopathogenesis of Human Immunodeficiency Virus: Implications for Immune‐Based Therapies
Sereti, I., & Lane, H. C. (2001) · Clinical Infectious Diseases · doi:10.1086/320758 · Cited by 29
Kessler, H. A., Johnson, J., Follansbee, S., Sension, M., Mildvan, D., Sepulveda, G. E., Bellos, N. C., & Hetherington, S. (2002) · Clinical Infectious Diseases · doi:10.1086/338638 · Cited by 24
Cited by
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A., & Lundgren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Deeks, S. G., Kitchen, C. M. R., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P., Martin, J. N., Kahn, J. O., Levy, J., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 804
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Metadata
- Authors
- Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., & Volberding, P. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-07-10
- Volume
- 288
- Issue
- 2
- Pages
- 222
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2139502307
- Cited by
- 709
- References
- 97
- FWCI
- 92.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.